Pelvic congestion syndrome

Mohamed Waseem Osman, Ilias Nikolopoulos, Kannamannadiar Jayaprakasan, Nicholas Raine‐Fenning
In: The Obstetrician & Gynaecologist · 2013 · vol. 15(3) , pp. 151–157 · doi:10.1111/tog.12031 · W2008280395
article OA: closed CC0 ⤵ 6 in-corpus citations
View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

Pelvic congestion syndrome, a significant cause of chronic pelvic pain, affects an estimated 3.8% of women of childbearing age and requires improved clinician awareness and diagnostic understanding.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Key content Pelvic congestion syndrome is a poorly understood condition that forms part of chronic pelvic pain syndrome – this makes up 10–40% of gynaecological outpatient department referrals. Pelvic congestion syndrome is thought to affect 3.8% of women of childbearing age yet the clinicians evaluating these patients are usually unaware of the condition and a significant number of trainees are not up to date with the current diagnostic and management options. Learning objectives To learn about the pathophysiology and the risk factors. To learn to recognise the condition. To be able to discuss various management options and choose a definitive mode of treatment tailored to individual need. Ethical issues Are we doing justice to patients if we as clinicians are not actually aware of this common and significant condition? Due to current gynaecological investigations not being able to diagnose this condition and general unawareness of the current available diagnostic tests, should we not be more aware of all the investigative modalities and the most appropriate ones for our patients so that a more definitive diagnosis can be made?

My notes (saved in your browser only)

Condition tags

chronic_pelvic_pain

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (39)

Cited by (6)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK